Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer

Human Gene Therapy

Volumn 18, Issue 10, 2007, Pages 895-906

  Mitsuhashi, Junko ^a,b   Tsukahara, Satomi ^a   Suzuki, Rieko ^a   Oh Hara, Yumiko ^b   Nishi, Saori ^b   Hosoyama, Hiroyo ^b   Katayama, Kazuhiro ^b   Noguchi, Kohji ^b   Minowa, Sayuri ^a   Shibata, Harumi ^a   Ito, Yoshinori ^a   Hatake, Kiyohiko ^a   Aiba, Keisuke ^c   Takahashi, Shunji ^a   Sugimoto, Yoshikazu ^a,b  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DOCETAXEL; MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CASE REPORT; CD34+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DOSE INCREASE; FOLLOW UP; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR CLONING; MULTIPLE CYCLE TREATMENT; NONHUMAN; POLYMERASE CHAIN REACTION; RETROVIRUS; T LYMPHOCYTE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS GENE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; NEOPLASM METASTASIS; P-GLYCOPROTEIN; RETROVIRIDAE; TAXOIDS; VIRUS INTEGRATION;

EID: 35348878723     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.075     Document Type: Article

References (35)

1. ABONOUR, R., WILLIAMS, D.A., EINHORN, L., HALL, K.M., CHEN, J., COFFMAN, J., TRAYCOFF, C.M., BANK, A., KATO, I., WARD, M., WILLIAMS, S.D., HROMAS, R., ROBERTSON, M.J., SMITH, F.O., WOO, D., MILLS, B., SROUR, E.F., and CORNETTA, K. (2000). Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat. Med. 6, 652-658.
2. AIUTI, A., SLAVIN, S., AKER, M., FICARA, F., DEOLA, S., MORTELLARO, A., MORECKI, S., ANDOLFI, G., TABUCCHI, A., CARLUCCI, F., MARINELLO, E., CATTANEO, F., VAI, S., SERVIDA, P., MINIERO, R., RONCAROLO, M.G., and BORDIGNON, C. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413.
3. ATTAL, M., HAROUSSEAU, J.L., STOPPA, A.M., SOTTO, J.J., FUZIBET, J.G., ROSSI, J.F., CASASSUS, P., MAISONNEUVE, H., FACON, T., IFRAH, N., PAYEN, C., and BATAILLE, R. (1996). A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myelome. N. Engl. J. Med. 335, 91-97.
4. + selected autologous peripheral blood cells transduced with a human ADA gene: Amendment to clinical research project. Project 90-C-195, January 10, 1992. Hum. Gene Ther. 4, 521-527.
5. CALMELS, B., FERGUSON, C., LAUKKANEN, M.O., ADLER, R., FAULHABER, M., KIM, H.J., SELLERS, S., HEMATTI, P., SCHMIDT, M., VON KALLE, C., AKAGI, K., DONAHUE, R.E., and DUNBAR, C.E. (2005). Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood 106, 2530-2533.
6. CAVAZZANA-CALVO, M., HACEIN-BEY, S., DE SAINT BASILE, G., GROSS, F., YVON, E., NUSBAUM, P., SELZ, F., HUE, C., CERTAIN, S., CASANOVA, J.L., BOUSSO, P., DEIST, F.L., and FISCHER, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672.
7. COWAN, K.H., MOSCOW, J.A., HUANG, H., ZUJEWSKI, J.A., O'SHAUGHNESSY, J., SORRENTINO, B., HINES, K., CARTER, C., SCHNEIDER, E., CUSACK, G., NOONE, M., DUNBAR, C., STEINBERG, S., WILSON, W., GOLDSPIEL, B., READ, E.J., LEITMAN, S.F., MCDONAGH, K., CHOW, C., ABATI, A., CHIANG, Y., CHANG, Y.N., GOTTESMAN, M.M., PASTAN, I., and NIENHUIS, A. (1999). Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin. Cancer Res. 5, 1619-1628.
8. GALSKI, H., SULLIVAN, M., WILLINGHAM, M.C., CHIN, K.V., GOTTESMAN, M.M., PASTAN, I., and MERLINO, G.T. (1989). Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: Resistance to daunomycin-induced leukopenia. Mol. Cell Biol. 9, 4357-4363.
9. GASPAR, H.B., PARSLEY, K.L., HOWE, S., KING, D., GILMORUR, K.C., SINCLAIR, J., BROUNS, G., SCHMIDT, M., VON KALLE, C., BARINGTON, T., JAKOBSEN, M.A., CHRISTENSEN, H.O., AL GHONAIUM, A., WHITE, H.N., SMITH, J.L., LEVINSKY, R.J., ALI, R.R., KINNON, C., and THRASHER, A.J. (2004). Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364, 2181-2187.
10. GOTTESMAN, M.M., and LING, V. (2006). The molecular basis of multidrug resistance in cancer: The early years of P-glycoprotein research. FEBS Lett. 580, 998-1009.
11. HACEIN-BEY-ABINA, S., LE DEIST, F., CARLIER, F., BOUNEAUD, C., HUE, C., DE VILLARTAY, J.P., THRASHER, A.J., WULFFRAAT, N., SORENSEN, R., DUPUIS-GIROD, S., FISCHER, A., DAVIES, E.G., KUIS, W., LEIVA, L., and CAVAZZANA-CALVO, M. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193.
12. HACEIN-BEY-ABINA, S., VON KALLE, C., SCHMIDT, M., MCCORMACK, M.P., WULFFRAAT, N., LEBOULCH, P., LIM, A., OSBORNE, C.S., PAWLIUK, R., MORILLON, E., SORENSEN, R., FORSTER, A., FRASER, P., COHEN, J.I., DE SAINT BASILE, G., ALEXANDER, I., WINTERGERST, U., FREBOURG, T., AURIAS, A., STOPPA-LYONNET, D., ROMANA, S., RADFORDWEISS, I., GROSS, F., VALENSI, F., DELABESSE, E., MACINTYRE, E., SIGAUX, F., SOULIER, J., LEIVA, L.E., WISSLER, M., PRINZ, C., RABBITTS, T.H., LE DEIST, F., FISCHER, A., and CAVAZZANA-CALVO, M. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
13. HANANIA, E.G., GILES, R.E., KAVANAGH, J., ELLERSON, D., ZU, Z., WANG, T., SU, Y., KUDELKA, A., RAHMAN, Z., HOLMES, F., HORTOBAGYI, G., CLAXTON, D., BACHIER, C., THALL, P., CHENG, S., HESTER, J., OSTROVE, J.M., BIRD, R.E., CHANG, A., KORBLING, M., SEONG, D., COTE, R., HOLZMAYER, T., MECHETNER, E., HEIMFELD, S., BERENSON, R., BURTNESS, B., EDWARDS, C., BAST, R., ANDREEFF, M., CHAMPLIN, R., and DEISSEROTH, A.B. (1996). Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc. Natl. Acad. Sci. U.S.A. 93, 15346-15351.
14. HESDORFFER, C., AYELLO, J., WARD, M., KAUBISCH, A., VAHDAT, L., BALMACEDA, C., GARRETT, T., FETELL, M., REISS, R., BANK, A., and ANTMAN, K. (1998). Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J. Clin. Oncol. 16, 165-172.
15. HIBINO, H., TANI, K., IKEBUCHI, K., WU, M.S., SUGIYAMA, H., NAKAZAKI, Y., TANABE, T., TAKAHASHI, S., TOJO, A., SUZUKI, S., TANIOKA, Y., SUGIMOTO, Y., NAKAHATA, T., and ASANO, S. (1999). The common marmoset as a target preclinical primate model for cytokine and gene therapy studies. Blood 93, 2839-2848.
16. ITO, Y., MUKAIYAMA, T., OGAWA, M., MIZUNUMA, N., TAKAHASHI, S., AIBA, K., and HORIKOSHI, N. (1999). Epirubicincontaining high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: Results of 5-year follow-up. Cancer Chemother. Pharmacol. 43, 8-12.
17. KIOKA, N., TSUBOTA, J., KAKEHI, Y., KOMANO, T., GOTTESMAN, M.M., PASTAN, I., and UEDA, K. (1989). P-glycoprotein gene (MDR1) cDNA from human adrenal: Normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem. Biophys. Res. Commun. 162, 224-231.
18. KOHN, D.B., SADELAIN, M., DUNBAR, C., BODINE, D., KIEM, H.P., CANDOTTI, F., TISDALE, J., RIVIERE, I., BLAU, C.A., RICHARD, R.E., SORRENTINO, B., NOLTA, J., MALECH, H., BRENNER, M., CORNETTA, K., CAVAGNARO, J., HIGH, K., and GLORIOSO, J. (2003). American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol. Ther. 8, 180-187.
19. KUSTIKOVA, O., FEHSE, B., MODLICH, U., YANG, M., DÜLLMANN, J., KAMINO, K., VON NEUHOFF, N., SCHLEGELBERGER, B., LI, Z., and BAUM, C. (2005). Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308, 1171-1174.
20. LOTZ, J.P., CURE, H., JANVIER, M., ASSELAIN, B., MORVAN, F., LEGROS, M., AUDHUY, B., BIRON, P., GUILLEMOT, M., GOUBET, J., LAADEM, A., CAILLIOT, C., MAIGNAN, C.L., DELOZIER, T., GLAISNER, S., MARANINCHI, D., ROCHE, H., and GISSELBRECHT, C. (2005). High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: Final results of the French multicentric randomised CMA/PEGASE 04 protocol. Eur. J. Cancer 41, 71-80.
21. MALECH, H.L., MAPLES, P.B., WHITING-THEOBALD, N., LINTON, G.F., SEKHSARIA, S., VOWELLS, S.J., LI, F., MILLER, J.A., DECARLO, E., HOLLAND, S.M., LEITMAN, S.F., CARTER, C.S., BUTZ, R.E., READ, E.J., FLEISHER, T.A., SCHNEIDERMAN, R.D., VAN EPPS, D.E., SPRATT, S.K., MAACK, C.A., ROKOVICH, J.A., COHEN, L.K., and GALLIN, J.I. (1997). Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc. Natl. Acad. Sci. U.S.A. 94, 12133-12138.
22. MCCORMACK, M.P., and RABBITTS, T.H. (2004). Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 350, 913-922.
23. MICKISCH, G.H., LICHT, T., MERLINO, G.T., GOTTESMAN, M.M., and PASTAN, I. (1991). Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: Efficacy, potency, and toxicity. Cancer Res. 51, 5417-5424.
24. R gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 94, 52-61.
25. OTT, M.G., SCHMIDT, M., SCHWARZWAELDER, K., STEIN, S., SILER, U., KOEHL, U., GLIMM, H., KUHLCKE, K., SCHILZ, A., KUNKEL, H., NAUNDORF, S., BRINKMANN, A., DEICHMANN, A., FISCHER, M., BALL, C., PILZ, I., DUNBAR, C., DU, Y., JENKINS, N.A., COPELAND, N.G., LUTHI, U., HASSAN, M., THRASHER, A.J., HOELZER, D., VON KALLE, C., SEGER, R., and GREZ, M. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401-409.
26. PETERS, W.P., DANSEY, R.D., KLEIN, J.L., and BAYNES, R.D. (2000). High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer. Oncologist 5, 1-13.
27. PHILIP, T., GUGLIELMI, C., HAGENBEEK, A., SOMERS, R., VAN DER LELIE, H., BRON, D., SONNEVELD, P., GISSELBRECHT, C., CAHN, J.-Y., HAROUSSEAU, J.-L., COIFFIER, B., BIRON, P., MANDELLI, F., and CHAUVIN, F. (1995). Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N. Engl. J. Med. 333, 1540-1545.
28. PIKE-OVERZET, K., DE RIDDER, D., WEERKAMP, F., BAERT, M.R., VERSTEGEN, M.M., BRUGMAN, M.H., HOWE, S.J., REINDERS, M.J., THRASHER, A.J., WAGEMAKER, G., VAN DONGEN, J.J., and STAAL, F.J. (2006). Is IL2RG oncogenic in Tcell development? Nature 443, E5
29. PODDA, S., WARD, M., HIMELSTEIN, A., RICHARDSON, C., DE LA FLOR-WEISS, E., SMITH, L., GOTTESMAN, M., PASTAN, I., and BANK, A. (1992). Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Acad. Sci. U.S.A. 89, 9676-9680.
30. SCHMIDT, M., ZICKLER, P., HOFFMANN, G., HAAS, S., WISSLER, M., MUESSIG, A., TISDALE, J.F., KURAMOTO, K., ANDREWS, R.G., WU, T., KIEM, H.P., DUNBAR, C.E., and VON KALLE, C. (2002). Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100, 2737-2743.
31. + cells from the cord blood of ADA-deficient SCID neonates. Nat. Med. 9, 463-468.
32. SORRENTINO, B.P., BRANDT, S.J., BODINE, D., GOTTESMAN. M., PASTAN. I., CLINE. A., NIENHUIS, A.W. (1992). Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257, 99-103.
33. SUGIMOTO, Y., TSUKAHARA, S., SATO, S., SUZUKI, M., NUNOI, H., MALECH, H.L., GOTTESMAN, M.M., and TSURUO, T. (2003). Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRESgp91. J. Gene Med. 5, 366-376.
34. TAKAHASHI, S., AIBA, K., ITO, Y., HATAKE, K., NAKANE, M., KOBAYASHI, T., MINOWA, S., SHIBATA, H., MITSUHASHI, J., TSUKAHARA, S., ISHIKAWA, E., SUZUKI, R., TSURUO, T., and SUGIMOTO, Y. (2007). MDR1 gene transfer into hematopoietic stem cells and maintenance of transduced leukocytes by docetaxel chemotherapy in metastatic breast cancer patients. Cancer Sci. 98, 1609-1616.
35. THRASHER, A.J., GASPAR, H.B., BAUM, C., MODLICH, U., SCHAMBACH, A., CANDOTTI, F., OTSU, M., SORRENTINO, B., SCOBIE, L., CAMERON, E., BLYTH, K., NEIL, J., ABINA, S.H., CAVAZZANA-CALVO, M., and FISCHER, A. (2006). XSCID transgene leukaemogenicity. Nature 443, E5-E6.